Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
dementia brainhealth riskfactors lifestyle Alzheimer's research

Jeff Borghoff

Patient Advisor

In March of 2016, at the age of 51, Jeff Borghoff was diagnosed with Younger Onset/Early-Stage Alzheimer’s Disease. Since Jeff’s diagnosis, he has worked with the national Alzheimer’s Association as a member of the National Early-Stage Advisory Group and currently serves on the board of directors for the Alzheimer’s Association Greater NJ chapter and as an Alzheimer’s Congressional Team member for his NJ district.  Jeff also serves on the NIH/NIA Genetic and Biomarker Disclosure Working Group – Patient/Participant Subcommittee among others. Jeff participated in the Biogen Aducanumab clinical trial for three years before it was terminated in March of 2019.

Sign up to our newsletter

Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.